Le Sage V, Werner B, Merrbach G, Petnuch S, OConnell A, Simmons H
Emerg Infect Dis. 2025; 31(3):477-487.
PMID: 40023796
PMC: 11878318.
DOI: 10.3201/eid3103.241485.
Desheva Y, Sergeeva M, Kudar P, Rekstin A, Romanovskaya-Romanko E, Krivitskaya V
Vaccines (Basel). 2025; 12(12.
PMID: 39771996
PMC: 11680112.
DOI: 10.3390/vaccines12121334.
Sidney J, Kim A, de Vries R, Peters B, Meade P, Krammer F
mBio. 2024; 16(2):e0347924.
PMID: 39714185
PMC: 11796400.
DOI: 10.1128/mbio.03479-24.
Le Sage V, Werner B, Merrbach G, Petnuch S, OConnell A, Simmons H
bioRxiv. 2024; .
PMID: 39484442
PMC: 11527028.
DOI: 10.1101/2024.10.23.619881.
Do T, Wille M, Wheatley A, Koutsakos M
J Virol. 2024; 98(10):e0118624.
PMID: 39360825
PMC: 11494982.
DOI: 10.1128/jvi.01186-24.
Headless hemagglutinin-containing influenza viral particles direct immune responses toward more conserved epitopes.
Hamele C, Luo Z, Leonard R, Spurrier M, Burke K, Webb S
J Virol. 2024; 98(10):e0116624.
PMID: 39324791
PMC: 11495035.
DOI: 10.1128/jvi.01166-24.
Antigenic drift and subtype interference shape A(H3N2) epidemic dynamics in the United States.
Perofsky A, Huddleston J, Hansen C, Barnes J, Rowe T, Xu X
Elife. 2024; 13.
PMID: 39319780
PMC: 11424097.
DOI: 10.7554/eLife.91849.
Multi-COBRA hemagglutinin formulated with cGAMP microparticles elicits protective immune responses against influenza viruses.
Zhang X, Shi H, Hendy D, Bachelder E, Ainslie K, Ross T
mSphere. 2024; 9(7):e0016024.
PMID: 38920382
PMC: 11288037.
DOI: 10.1128/msphere.00160-24.
Capsid virus-like particle display improves recombinant influenza neuraminidase antigen stability and immunogenicity in mice.
Kang H, Martinez M, Aves K, Okholm A, Wan H, Chabot S
iScience. 2024; 27(6):110038.
PMID: 38883830
PMC: 11179578.
DOI: 10.1016/j.isci.2024.110038.
Anti-neuraminidase immunity in the combat against influenza.
Zhang X, Ross T
Expert Rev Vaccines. 2024; 23(1):474-484.
PMID: 38632930
PMC: 11157429.
DOI: 10.1080/14760584.2024.2343689.
Multi-COBRA hemagglutinin formulated with cGAMP microparticles elicit protective immune responses against influenza viruses.
Zhang X, Shi H, Hendy D, Bachelder E, Ainslie K, Ross T
bioRxiv. 2024; .
PMID: 38464191
PMC: 10925245.
DOI: 10.1101/2024.02.27.582355.
Leveraging vaccination-induced protective antibodies to define conserved epitopes on influenza N2 neuraminidase.
Lei R, Kim W, Lv H, Mou Z, Scherm M, Schmitz A
Immunity. 2023; 56(11):2621-2634.e6.
PMID: 37967533
PMC: 10655865.
DOI: 10.1016/j.immuni.2023.10.005.
Always a bridesmaid, never a bride: Committing to flu neuraminidase as a vaccine target.
Schneider C, Coughlan L
Mol Ther. 2023; 31(7):1865-1867.
PMID: 37201525
PMC: 10362412.
DOI: 10.1016/j.ymthe.2023.04.014.
Spatial genetic structure of 2009 H1N1 pandemic influenza established as a result of interaction with human populations in mainland China.
Kim S, Carrel M, Kitchen A
PLoS One. 2023; 18(5):e0284716.
PMID: 37196010
PMC: 10191359.
DOI: 10.1371/journal.pone.0284716.
An ELISA-based assay for determining haemagglutinin potency in egg, cell, or recombinant protein derived influenza vaccines.
Bodle J, Vandenberg K, Laurie K, Barr I, Zhang Y, Rockman S
Front Immunol. 2023; 14:1147028.
PMID: 37033922
PMC: 10073703.
DOI: 10.3389/fimmu.2023.1147028.
Characterizing a century of genetic diversity and contemporary antigenic diversity of N1 neuraminidase in influenza A virus from North American swine.
Hufnagel D, Young K, Arendsee Z, Gay L, Caceres C, Rajao D
Virus Evol. 2023; 9(1):vead015.
PMID: 36993794
PMC: 10041950.
DOI: 10.1093/ve/vead015.
Immune Control of Avian Influenza Virus Infection and Its Vaccine Development.
Dey P, Ahuja A, Panwar J, Choudhary P, Rani S, Kaur M
Vaccines (Basel). 2023; 11(3).
PMID: 36992177
PMC: 10058720.
DOI: 10.3390/vaccines11030593.
Neuraminidase delivered as an APC-targeted DNA vaccine induces protective antibodies against influenza.
Werninghaus I, Hinke D, Fossum E, Bogen B, Braathen R
Mol Ther. 2023; 31(7):2188-2205.
PMID: 36926694
PMC: 10362400.
DOI: 10.1016/j.ymthe.2023.03.012.
Establishment of a Pseudovirus Platform for Neuraminidase Inhibiting Antibody Analysis.
Desheva Y, Petkova N, Losev I, Guzhov D, Go A, Chao Y
Int J Mol Sci. 2023; 24(3).
PMID: 36768700
PMC: 9916614.
DOI: 10.3390/ijms24032376.
Production and Validation of Neuraminidase Derived from Genotype 4 Reassortant Eurasian Avian-like H1N1 Virus as a Vaccine Candidate.
Kim D, Lee S, Geem K, Kim J, Kim E, Lee D
Plants (Basel). 2022; 11(21).
PMID: 36365437
PMC: 9655071.
DOI: 10.3390/plants11212984.
